MariMed Inc. (OTCMKTS:MRMD – Get Free Report) saw a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 1,000 shares, a decline of 97.8% from the September 15th total of 44,669 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,661,239 shares, the short-interest ratio is currently 0.0 days.
MariMed Stock Performance
MRMD traded down $0.00 on Friday, reaching $0.06. The company had a trading volume of 192,523 shares, compared to its average volume of 715,688. MariMed has a 1 year low of $0.06 and a 1 year high of $0.18. The stock has a market capitalization of $25.55 million, a PE ratio of -1.58 and a beta of 1.39. The company has a quick ratio of 0.34, a current ratio of 0.92 and a debt-to-equity ratio of 1.78. The stock has a 50-day moving average price of $0.07 and a 200-day moving average price of $0.07.
MariMed (OTCMKTS:MRMD – Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The company had revenue of $41.92 million for the quarter, compared to the consensus estimate of $39.80 million. MariMed had a negative net margin of 9.13% and a negative return on equity of 10.71%.
About MariMed
MariMed, Inc is a U.S.-based cannabis company that develops, operates, and manages state-licensed cannabis businesses. Its activities include cannabis cultivation, product manufacturing, wholesale distribution, and retail dispensary operations.
The company offers cannabis products such as flower, pre-rolls, concentrates, edibles, tinctures, and topical products. Its portfolio has included brands such as Betty’s Eddies, Nature’s Heritage, InHouse, and Kalm Fusion, which are distributed through MariMed-operated dispensaries and other licensed retail channels.
MariMed serves regulated cannabis markets in multiple states, including Massachusetts, Maryland, Delaware, and Ohio.
See Also
- Five stocks we like better than MariMed
- 3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
- Home Depot and Lowe’s Hit 52-Week Lows—But Analysts Aren’t Giving Up
- Utilities Are Bouncing Back—These 2 Giants Could Signal the Next Big Sector Rally
- Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes Next
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
